-
-
-
-
-
-
-
Pfizer vows to continue Metsera legal fight after court denies restraining order
-
-
-
-
-
-
-
Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit
-
-
-
-
-
-
-
Novo Nodrisk stock dips on aggressive odder to buy Metsera, 'reckless' says Pfizer
-
-
-
-
-
-
-
Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3
-
-
-
-
-
-
-
Wall Street bullish on Metsera following January IPO on obesity drug pipeline
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

